The RNA methyltransferase METTL16 enhances cholangiocarcinoma growth through PRDM15-mediated FGFR4 expression
Abstract Background RNA N6-Methyladenosine (m6A) modification is implicated in the progression of human cancers including cholangiocarcinoma (CCA). METTL16 is recently identified as a new RNA methyltransferase responsible for m6A modification, although the role of METTL16 in CCA has not yet been exa...
Main Authors: | Nianli Liu, Jinqiang Zhang, Weina Chen, Wenbo Ma, Tong Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-10-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13046-023-02844-5 |
Similar Items
-
Proof-of-Concept Method to Study Uncharacterized Methyltransferases Using PRDM15
by: Li-Na Zhao, et al.
Published: (2023-01-01) -
MECOM/PRDM3 and PRDM16 Serve as Prognostic-Related Biomarkers and Are Correlated With Immune Cell Infiltration in Lung Adenocarcinoma
by: Meng Li, et al.
Published: (2022-01-01) -
Targeted Therapies in Advanced Cholangiocarcinoma: A Focus on FGFR Inhibitors
by: Alessandro Rizzo
Published: (2021-05-01) -
PRDM16 regulates arterial development and vascular integrity
by: Michael Thompson, et al.
Published: (2023-06-01) -
Protein PRDM16 and its importance for adipose tissue (literature review)
by: L. N. Afanaskina, et al.
Published: (2023-10-01)